Literature DB >> 15731267

The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.

Melissa L Kelley1, Kerri E Keiger, Chan Jae Lee, Jon M Huibregtse.   

Abstract

The function of the human papillomavirus (HPV) E6 protein that is most clearly linked to carcinogenesis is the targeted degradation of p53, which is dependent on the E6AP ubiquitin ligase. Additional functions have been attributed to E6, including the stimulation of telomerase activity and the targeted degradation of other cellular proteins, but in most cases it is unclear whether these activities are also E6AP dependent. While E6 clearly influences the transcriptional program of HPV-positive cell lines through the inactivation of p53, it has been shown that at least a subset of its p53-independent functions are also reflected in the transcriptional program. For this study, we have determined the extent to which E6AP is involved in mediating the set of E6 functions that impact on the global transcriptional program of HPV-positive cell lines. The transcriptional profiles of approximately 31,000 genes were characterized for three cell lines (HeLa, Caski, and SiHa cells) after small interfering RNA (siRNA)-mediated silencing of E6 or E6AP. We found that E6 and E6AP siRNAs elicited nearly identical alterations in the transcriptional profile of each cell line. Some of the expression alterations were apparent secondary effects of p53 stabilization, while the basis of most other changes was not reconcilable with previously proposed E6 functions. While expression changes of the TERT gene (telomerase catalytic subunit) were not revealed by the array, telomerase repeat amplification protocol assays showed that both E6 and E6AP knockouts resulted in a suppression of telomerase activity. Together, these results suggest that E6AP mediates a broad spectrum of E6 functions, including virtually all functions that impact on the transcriptional program of HPV-positive cell lines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731267      PMCID: PMC1075713          DOI: 10.1128/JVI.79.6.3737-3747.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  A revised picture of the E2F transcriptional network and RB function.

Authors:  Olivier Stevaux; Nicholas J Dyson
Journal:  Curr Opin Cell Biol       Date:  2002-12       Impact factor: 8.382

2.  Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.

Authors:  D Gardiol; C Kühne; B Glaunsinger; S S Lee; R Javier; L Banks
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

Review 3.  Papillomaviruses and cancer: from basic studies to clinical application.

Authors:  Harald zur Hausen
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

4.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

5.  Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.

Authors:  Eva Kehmeier; Heiko Rühl; Britta Voland; Melissa Conrad Stöppler; Elliot Androphy; Hubert Stöppler
Journal:  Virology       Date:  2002-07-20       Impact factor: 3.616

6.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.

Authors:  Ming Jiang; Jo Milner
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

7.  Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.

Authors:  Miranda Thomas; Richard Laura; Karin Hepner; Ernesto Guccione; Charles Sawyers; Laurence Lasky; Lawrence Banks
Journal:  Oncogene       Date:  2002-08-01       Impact factor: 9.867

8.  Database resources of the National Center for Biotechnology.

Authors:  David L Wheeler; Deanna M Church; Scott Federhen; Alex E Lash; Thomas L Madden; Joan U Pontius; Gregory D Schuler; Lynn M Schriml; Edwin Sequeira; Tatiana A Tatusova; Lukas Wagner
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

9.  Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.

Authors:  Chan Jae Lee; Eun Jung Suh; Hyun Tae Kang; Jun Sub Im; Soo Jong Um; Jong Sup Park; Eun Seong Hwang
Journal:  Exp Cell Res       Date:  2002-07-15       Impact factor: 3.905

Review 10.  Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.

Authors:  Martin Scheffner; Noel J Whitaker
Journal:  Semin Cancer Biol       Date:  2003-02       Impact factor: 15.707

View more
  45 in total

1.  Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.

Authors:  Gustavo Martínez-Noël; Jeffrey T Galligan; Mathew E Sowa; Verena Arndt; Thomas M Overton; J Wade Harper; Peter M Howley
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells.

Authors:  Rita Crinelli; Marzia Bianchi; Michele Menotta; Elisa Carloni; Elisa Giacomini; Marzia Pennati; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396

3.  Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome.

Authors:  Daphna Zaaroor-Regev; Prim de Bie; Martin Scheffner; Tahel Noy; Ruth Shemer; Maya Heled; Ilan Stein; Eli Pikarsky; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

4.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

5.  HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

Authors:  Xuefeng Liu; Jeffrey Roberts; Aleksandra Dakic; Yiyu Zhang; Richard Schlegel
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

6.  HPV E6 protein interacts physically and functionally with the cellular telomerase complex.

Authors:  Xuefeng Liu; Aleksandra Dakic; Yiyu Zhang; Yuhai Dai; Renxiang Chen; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

7.  Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53.

Authors:  Arnd Hengstermann; Michael A D'silva; Petric Kuballa; Karin Butz; Felix Hoppe-Seyler; Martin Scheffner
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

8.  Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.

Authors:  Nicole Brimer; Charles Lyons; Scott B Vande Pol
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

9.  Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.

Authors:  Vjekoslav Tomaic; David Pim; Miranda Thomas; Paola Massimi; Michael P Myers; Lawrence Banks
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

10.  Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes.

Authors:  Mark A Merkley; Ellen Hildebrandt; Robert H Podolsky; Hilal Arnouk; Daron G Ferris; William S Dynan; Hubert Stöppler
Journal:  Proteome Sci       Date:  2009-08-23       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.